Measuring Exposure to Opioids Using Self‐Reported Medication Use Data Versus General Practitioner Prescription Records in the <scp>UK</scp> Biobank Study
This analysis indicates that self-reported regular opioid use in the UKBB could be a valid indicator for identifying individuals with repeated prescriptions for analgesic opioids in the past year, while also capturing opioid use from non-linked sources. However, agreement was low for non-analgesic opioids, suggesting limited utility of self-report for capturing use of these medications.
Authors
- Louisa Degenhardt (ORCID: https://orcid.org/0000-0002-8513-2218)
- Mahdi Sheikh (ORCID: https://orcid.org/0000-0003-3972-7824)
- Sallie‐Anne Pearson (ORCID: https://orcid.org/0000-0001-7137-6855)
- Allison Domingues (ORCID: https://orcid.org/0000-0003-1804-6237)
- Marie‐Odile Parat (ORCID: https://orcid.org/0000-0003-4895-7381)
- Vivian Viallon (ORCID: https://orcid.org/0000-0002-9799-4421)
- Jifang Zhou (ORCID: https://orcid.org/0000-0003-2590-8667)
- Yue Zhai (ORCID: https://orcid.org/0000-0002-9733-7042)
Institutions
- The University of Sydney (AU)
- China Pharmaceutical University (CN)
- The University of Queensland (AU)
- UNSW Sydney (AU)
- Centre international de recherche sur le cancer (FR)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/pds.70280
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- World Health Organization
- Institut National Du Cancer
- Institut pour la Recherche en Santé Publique
- National Institutes of Health
- National Cancer Institute